shutterstock_1960556293_molly_woodward

Molly Woodward / Shutterstock.com

15 February 2024Big PharmaLiz Hockley

Pfizer to pay out $93m to end antitrust suit

US pharma firm has not admitted liability as part of agreement with Lipitor buyers following a long-running dispute over a cholesterol drug | Litigation against Sun Pharma’s Ranbaxy will continue.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Pfizer and BioNTech allege inconsistencies in Moderna’s COVID-19 statements

1 February 2024 Pharma giants raise concerns about Moderna’s COVID-19 vaccine patents | Company's statements to the FDA and PTAB contain "inconsistencies" | Appeals Board urged to scrutinise assertions.

Moderna and Pfizer face fresh suits over COVID-19 vaccine

30 May 2023 A US biotech is accusing the pair of infringing several of its “foundational” lipid particle patents | Pfizer and BioNTech accused plaintiff in earlier suit of antitrust in a dispute over one of the patents at issue.

More on this story

Moderna and Pfizer face fresh suits over COVID-19 vaccine

30 May 2023 A US biotech is accusing the pair of infringing several of its “foundational” lipid particle patents | Pfizer and BioNTech accused plaintiff in earlier suit of antitrust in a dispute over one of the patents at issue.

Pfizer and BioNTech allege inconsistencies in Moderna’s COVID-19 statements

1 February 2024 Pharma giants raise concerns about Moderna’s COVID-19 vaccine patents | Company's statements to the FDA and PTAB contain "inconsistencies" | Appeals Board urged to scrutinise assertions.

More on this story

Moderna and Pfizer face fresh suits over COVID-19 vaccine

30 May 2023 A US biotech is accusing the pair of infringing several of its “foundational” lipid particle patents | Pfizer and BioNTech accused plaintiff in earlier suit of antitrust in a dispute over one of the patents at issue.

Pfizer and BioNTech allege inconsistencies in Moderna’s COVID-19 statements

1 February 2024 Pharma giants raise concerns about Moderna’s COVID-19 vaccine patents | Company's statements to the FDA and PTAB contain "inconsistencies" | Appeals Board urged to scrutinise assertions.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent